Brazil’s Ambev Q2 net profit falls 15%, lands below estimates

By Natalia Siniawski (Reuters) -Brazilian brewer Ambev on Thursday reported a 15.2% decline in second-quarter net profit, narrowly missing market forecasts, but said it expects cost pressures this year to be milder than previously anticipated. The subsidiary of Belgium’s Anheuser-Busch InBev posted profit of 2.60 billion reais ($540.34 million), below the 2.68 billion reais average…

Read More

Apollo’s second-quarter earnings surge 75% on upbeat annuities business

By Chibuike Oguh NEW YORK (Reuters) – Apollo Global Management Inc said on Thursday its second-quarter adjusted net income jumped 75% year-on-year, underpinned by strong growth in earnings from its retirement services business and management fees. Adjusted net income rose to $1 billion, up from $576 million a year earlier. That translated to an adjusted…

Read More

US psychiatrists prescribe Wegovy to battle medication-induced weight gain

By Elissa Welle NEW YORK (Reuters) – U.S. psychiatrists are increasingly prescribing the popular weight-loss drug Wegovy to patients who gain weight from medicines used to treat mental disorders, such as schizophrenia or bipolar disorder, according to Reuters interviews with ten prescribers across the country. Many antipsychotic drugs and mood stabilizers can cause patients to…

Read More

GM’s Cruise says it’s reached the robotaxi industry’s first union agreements

By Anna Tong (Reuters) – Cruise, General Motors’ robotaxi unit, said on Thursday it had signed the driverless car industry’s first labor union agreements, a significant milestone as unions and robotaxi firms have historically been at odds. The company is partnering with two local San Francisco union chapters that represent electrical workers and janitors, the…

Read More

Merck KGaA flags steeper profit drop on lower orders from drugmakers

By Ludwig Burger FRANKFURT (Reuters) -Germany’s Merck KGaA on Thursday warned of a steeper earnings decline due to a slump in demand for materials used to produce pharmaceuticals and semiconductors, as its high-tech niche markets get drawn into a wider downturn. In a statement, it cited “persistently high inventory levels of our Life Science customers,…

Read More